Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesis.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
04 2021
Historique:
received: 06 05 2020
revised: 24 07 2020
accepted: 10 08 2020
pubmed: 26 1 2021
medline: 3 8 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

To study the biological effects of resveratrol on the growth, electrophysiology, and mitochondrial function of human granulosa cells (h-GCs). Preclinical study. Electrophysiology laboratory and in vitro fertilization unit. This study included h-GCs from seven infertile women undergoing assisted reproductive techniques. Human ovarian Granulosa Cell Tumor (GCT) cell line COV434 and h-GCs obtained after oocyte retrieval were cultured in the absence or presence of resveratrol. Granulosa cells were evaluated for cell viability and mitochondrial activity. Electrophysiological recordings and evaluation of potassium current (IKur) and Ca Resveratrol induced mitochondrial activity in a bell-shaped, dose-effect-dependent manner. Specifically, resveratrol treatment (3 μM, 48 hours) increased ATP production and cell viability and promoted the induction of cellular differentiation. These biological changes were associated with mitochondrial biogenesis. Electrophysiological recordings showed that resveratrol reduced the functional expression of an ultra rapid activating, slow inactivating, delayed rectifier potassium current (IKur) that is associated with a plasma membrane depolarization and that promotes an increase in intracellular Ca

Identifiants

pubmed: 33487442
pii: S0015-0282(20)30770-6
doi: 10.1016/j.fertnstert.2020.08.016
pii:
doi:

Substances chimiques

Antioxidants 0
Resveratrol Q369O8926L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1063-1073

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Francesco Ragonese (F)

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy.

Lorenzo Monarca (L)

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy; Department of Experimental Medicine, Perugia Medical School, University of Perugia, Perugia, Italy.

Antonella De Luca (A)

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy.

Loretta Mancinelli (L)

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy.

Monica Mariani (M)

Centre of Assisted Reproductive Technologies, S. Maria della Misericordia Hospital, Perugia, Italy.

Cristina Corbucci (C)

Centre of Assisted Reproductive Technologies, S. Maria della Misericordia Hospital, Perugia, Italy.

Sandro Gerli (S)

Department of Surgical and Biomedical Sciences, Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy.

Rossana Giulietta Iannitti (RG)

S&R Farmaceutici S.p.A Bastia Umbra, Perugia, Italy.

Lucio Leonardi (L)

S&R Farmaceutici S.p.A Bastia Umbra, Perugia, Italy.

Bernard Fioretti (B)

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy. Electronic address: bernard.fioretti@unipg.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH